ERYTECH Pharma Announces Revenue Results for the Fourth Quarter and Year to Date of Fiscal Year 2013
For the year total revenues were amounting to EUR 0.86 million, related to tax income credits for development activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 EUR | -0.10% | -1.49% | -53.19% |
07-03 | Phaxiam: EPIC Bpifrance exceeds 25% of share capital | CF |
06-28 | Would you like some more inflation? |
1st Jan change | Capi. | |
---|---|---|
+21.12% | 127B | |
+23.53% | 116B | |
+25.15% | 27.69B | |
-19.29% | 19.62B | |
-16.57% | 16.26B | |
-16.35% | 15.49B | |
+11.64% | 14.81B | |
-46.65% | 14.39B | |
+56.78% | 14.11B |